Question 1

What are the potential side effects of Nadofaragene Firadenovec?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis clinical trial (NCT06668493). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis clinical trial (NCT06668493). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis clinical trial (NCT06668493). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the eligibility criteria, and do I meet them?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis clinical trial (NCT06668493). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis clinical trial (NCT06668493). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or if the treatment does not work?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis clinical trial (NCT06668493). Contact the study team or your healthcare provider for specific answers.

What this study is about